Results 131 to 140 of about 89,228 (352)
Maxillary Sinus Papillary Edema as a Predictor of Odontogenic Sinusitis
The Laryngoscope, EarlyView.Maxillary sinus papillary edema (MSPE) is a distinct finding that is reliably identifiable, and is significantly more likely in odontogenic sinusitis (ODS) compared to infectious chronic rhinosinusitis without nasal polyps and noninfectious chronic rhinosinusitis with nasal polyps.
Hussein Mackie +6 more
wiley +1 more source
The use of silver preparations in the treatment of acute rhinosinusitis
Медицинский совет, 2016 ARVI and flu epidemics occur annually and affect up to 15% of the world population. One of the most common diseases associated with acute respiratory infection is acute rhinosinusitis.
N. A. Miroshnichenko +2 more
doaj +1 more source
Impaired local VD3 metabolism contributes to tissue neutrophilic inflammation in chronic rhinosinusitis with nasal polyps [PDF]
, 2023 Qiao Xiao
openalex +1 more source
Otolaryngology–Head and Neck Surgery, EarlyView.Abstract Environmental factors, including airborne toxicants, are thought to contribute to the pathogenesis of chronic rhinosinusitis, although the exact mechanism is not fully understood. The purpose of this pilot study is to assess the impact of pesticide, N,N‐diethyl‐meta‐toluamide (DEET), on the sinonasal epithelium using an in vivo murine model ...
Jivianne T. Lee +4 more
wiley +1 more source
Siriraj Medical Journal, 2014 Background: Chronic rhinosinusitis is a common problem in patients with allergic rhinitis or antibody deficiency. Topical antibiotic therapy for chronic sinusitis has been shown to improve symptoms and quality of life in adults.
Suruthai Kurasirikul +3 more
doaj
PLACE OF MUKOACTIVE THERAPY OF RINOSINUSITIS IN INTERNATIONAL AND RUSSIAN GUIDELINES
Медицинский совет, 2017 Excessive accumulation of mucous secretions in the nasal cavity and paranasal sinuses is key drivers in the pathogenesis of rhinosinusitis. Mucoactive drugs are actively used to combat this phenomenon.
S. V. Ryazantsev +2 more
doaj +1 more source
Otolaryngology–Head and Neck Surgery, EarlyView.Abstract Objective Previous studies have suggested a benefit to early functional endoscopic sinus surgery (FESS) for chronic rhinosinusitis (CRS). With the approval of T2 biologics for CRS with nasal polyps (CRSwNP), it is important to re‐evaluate FESS timing in relation to T2 biologic utilization.
Radhika Duggal +4 more
wiley +1 more source
RHINOSINUSITIES THERAPY: PRESENT AND FUTURE
Медицинский совет, 2017 The article presents the aspects of medical therapy of rhinosinusitis from the point of view of the disease pathogenesis. It is shown in which cases the indication of a systemic antibacterial therapy, the choice of optimal antibiotic given the current ...
V. V. Shilenkova
doaj +1 more source
Rheumatology &Autoimmunity, EarlyView.This observational study assessed the association between anti‐type 2 biologic agents and the occurrence of autoimmune diseases using a large real‐world claims database. Anti‐IL‐5 and anti‐IgE therapies were associated with an increased occurrence of autoimmune diseases, including rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE ...
Shoichiro Inokuchi
wiley +1 more source
Pathogenetic therapy of rhinosinusites in the practice of otorhinolaryngologist
Медицинский совет, 2019 An important and topical problem of modern otorhinolaryngology is the search for effective and safe medicines for the treatment of bacterial sinusitis, which is one of the most common human diseases, and this problem is becoming more and more acute every
S. V. Ryazantsev +2 more
doaj +1 more source